[PDF][PDF] Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B
LR Silverman, EP Demakos, BL Peterson… - Journal of Clinical …, 2002 - scholar.archive.org
Purpose: Patients with high-risk myelodysplastic syndrome (MDS) have high mortality from
bone marrow failure or transformation to acute leukemia. Supportive care is standard …
bone marrow failure or transformation to acute leukemia. Supportive care is standard …
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
LR Silverman, EP Demakos, BL Peterson… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: Patients with high-risk myelodysplastic syndrome (MDS) have high mortality
from bone marrow failure or transformation to acute leukemia. Supportive care is standard …
from bone marrow failure or transformation to acute leukemia. Supportive care is standard …
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B
LR Silverman, EP Demakos… - Journal of clinical …, 2002 - pubmed.ncbi.nlm.nih.gov
Purpose Patients with high-risk myelodysplastic syndrome (MDS) have high mortality from
bone marrow failure or transformation to acute leukemia. Supportive care is standard …
bone marrow failure or transformation to acute leukemia. Supportive care is standard …
[引用][C] Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
LR SILVERMAN, EP DEMAKOS… - Journal of clinical …, 2002 - pascal-francis.inist.fr
Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A
study of the cancer and leukemia group B CNRS Inist Pascal-Francis CNRS Pascal and …
study of the cancer and leukemia group B CNRS Inist Pascal-Francis CNRS Pascal and …
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.
LR Silverman, EP Demakos, BL Peterson… - Journal of Clinical …, 2002 - europepmc.org
Purpose Patients with high-risk myelodysplastic syndrome (MDS) have high mortality from
bone marrow failure or transformation to acute leukemia. Supportive care is standard …
bone marrow failure or transformation to acute leukemia. Supportive care is standard …
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
LR Silverman, EP Demakos, BL Peterson… - Journal of Clinical …, 2002 - cir.nii.ac.jp
< jats: p> PURPOSE: Patients with high-risk myelodysplastic syndrome (MDS) have high
mortality from bone marrow failure or transformation to acute leukemia. Supportive care is …
mortality from bone marrow failure or transformation to acute leukemia. Supportive care is …
[引用][C] Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B
S LR - J Clin Oncol, 2002 - cir.nii.ac.jp
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome : a
study of the cancer and leukemia group B | CiNii Research CiNii 国立情報学研究所 学術情報 …
study of the cancer and leukemia group B | CiNii Research CiNii 国立情報学研究所 学術情報 …